CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA: Release of a capital market information
CompuGroup Medical SE & Co. KGaA
/ Share Buy-Back
Disclosure pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 CompuGroup Medical SE & Co. KGaA: Share Buy-Back Program – 7th Interim Announcement In the period from April 12, 2021 until and including April 16, 2021, CompuGroup Medical SE & Co. KGaA has bought back an aggregate number of 125,996 shares in CompuGroup Medical SE & Co. KGaA within its share buy-back program which had been announced on February 25, 2021 pursuant to Art. 2 para. 1 Commission Delegated Regulation (EU) No 2016/1052 to start on February 26, 2021 and which has been increased and extended as per announcement on March 25, 2021. The aggregate number of shares bought back each day during the period from April 12, 2021 until and including April 16, 2021 as well as the daily volume-weighted average prices for such buy-backs are as follows:
The aggregate number of shares bought back within the share buy-back program in the period from February 26, 2021 until and including April 16, 2021 amounts to 890,917 shares. Detailed information about the transactions are published on the company’s website under www.cgm.com/sbb. The acquisitions of the shares in CompuGroup Medical SE & Co. KGaA were carried out by a credit institution assigned by CompuGroup Medical SE & Co. KGaA exclusively via the Frankfurt Stock Exchange (XETRA trading). Koblenz, April 19, 2021 CompuGroup Medical SE & Co. KGaA
19.04.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | CompuGroup Medical SE & Co. KGaA |
Maria Trost 21 | |
56070 Koblenz | |
Germany | |
Internet: | www.cgm.com |
End of News | DGAP News Service |